TrialThe Lancet. Respiratory medicine2015

Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.

Caryn Lerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.